Adaptation and Evaluation of SHARE: A Palliative Care Intervention for Head and Neck Cancer Patients and their Caregivers

SHARE 的适应和评估:针对头颈癌患者及其护理人员的姑息治疗干预措施

基本信息

  • 批准号:
    10397122
  • 负责人:
  • 金额:
    $ 16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-23 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Many efficacious family-based interventions (FBIs) exist in cancer, but few have been integrated in routine care because they have not been designed/reported in a way that supports implementation. Barriers include resource- intensive designs that are incompatible with clinical workflows (e.g., multiple in-person visits or phone sessions with healthcare service providers) and a lack of healthcare reimbursement for services provided to caregivers. Making delivery channel adaptations could facilitate clinical uptake, and improve outcomes, but little guidance for adapting in-person/telephone-based FBIs for delivery via web/mobile platforms exists. This study uses Implementation Science (IS) and human-computer interaction principles to develop a model for adapting FBIs for digital delivery with the goal of improving uptake in oncology clinical care settings. We will adapt a highly promising telephone-based FBI called SHARE (Spouses coping with the Head and neck Radiation Experience) for delivery via mobile web (AIM 1), evaluate the feasibility, acceptability and non-inferiority of the new SHARE 2.0 prototype (AIM 2A), and elucidate factors that may influence implementation of SHARE 2.0 (AIM 2B). For AIM 1, we will adapt SHARE through collaborative efforts by assembling a stakeholder advisory committee (SAC) of 6 HNC patients and 6 caregivers to provide feedback on unadapted SHARE materials and desired technical features of SHARE 2.0 to inform an adaptation blueprint. Next, we will apply the Accelerated Creation-to- Sustainment (ACTS) model to iteratively develop SHARE 2.0 followed by usability testing with 5 patients and 5 caregivers. The outcome will be a functional prototype that is free from significant usability errors. For AIM 2A, we will conduct a single-arm trial of SHARE 2.0 with 65 patient-caregiver dyads. Participants complete surveys before initiating external beam radiation therapy (EBRT) and 1 month post-EBRT. We will judge the trial feasible and acceptable if results are consistent with at least 70% of eligible patients/caregivers enrolling and at least 80% reporting satisfaction with content/logistics. We will also examine whether SHARE 2.0 performs comparably to SHARE by comparing findings from this trial to the results of the original SHARE pilot trial. For AIM 2B, we will apply the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) QuEST (Qualitative Evaluation for Systematic Translation) mixed-methods framework to identify individual/organizational factors that may influence future adoption, implementation, and sustainability of SHARE 2.0 before proceeding to a hybrid implementation-effectiveness trial. Overall, this study will yield a functioning technology-enabled intervention that delivers symptom-management support, and meets the needs of stakeholders, thereby maximizing likelihood of uptake and sustainability in oncology clinical care. If successful, it could serve as a model for adapting other FBIs for digital delivery and improve palliative and supportive care delivery in cancer.
项目摘要 许多有效的以家庭为基础的干预(FBIs)存在于癌症,但很少有被纳入常规护理 因为它们的设计/报告方式不支持执行。障碍包括资源- 与临床工作流程不兼容的密集设计(例如,多次亲自访问或电话会议 与保健服务提供者)和缺乏对提供给照顾者的服务的保健报销。 调整输送通道可以促进临床吸收,改善结果,但指导很少 用于使基于个人/电话的FBI适于经由web/移动的平台递送。本研究采用 实施科学(IS)和人机交互原理,以开发适应FBIs的模型 用于数字交付,目标是提高肿瘤学临床护理环境中的使用率。我们将适应一个高度 有前途的电话为基础的联邦调查局称为共享(配偶应付头部和颈部辐射的经验) 对于通过移动的网络(AIM 1)递送,评价新SHARE的可行性、可接受性和非劣效性 2.0原型(AIM 2A),并阐明可能影响SHARE 2.0(AIM 2B)实施的因素。为 目标1,我们将通过组建利益相关者咨询委员会(SAC), 6名HNC患者和6名护理人员提供关于不适用的SHARE材料和所需技术的反馈 共享2.0的功能,为适应蓝图提供信息。接下来,我们将应用加速创建- 支持(SHARE)模型,以迭代开发SHARE 2.0,然后对5名患者和5名 照顾者其结果将是一个功能原型,没有重大的可用性错误。对于AIM 2A, 我们将对65名患者-护理人员进行SHARE 2.0的单臂试验。参与者完成调查 开始外照射放射治疗(EBRT)前和EBRT后1个月。我们将判断试验可行 如果结果与至少70%的合格患者/护理人员入组一致,并且 80%的人对内容/物流表示满意。我们还将检查SHARE 2.0是否执行了 通过将本试验的结果与最初的SHARE试点试验的结果进行比较,对于AIM 2B,我们 将应用RE-AIM(覆盖范围、有效性、采用、实施、维护)QuEST(定性 系统翻译评估)混合方法框架,以确定 可能会影响SHARE 2.0未来的采用、实施和可持续性,然后再进行混合 实施效果试验。总的来说,这项研究将产生一个功能性的技术支持的干预措施, 提供企业管理支持,满足利益相关者的需求,从而最大限度地提高 肿瘤临床护理的吸收和可持续性。如果成功的话,它可以作为一个模型, FBIs用于数字交付并改善癌症的姑息和支持性护理交付。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hoda J Badr其他文献

Hoda J Badr的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hoda J Badr', 18)}}的其他基金

OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10408739
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10175490
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10643856
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Supplement: Effects of Comorbidity Management and Complex Care Coordination on Cancer Caregivers
补充:合并症管理和复杂护理协调对癌症护理人员的影响
  • 批准号:
    10818788
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Adaptation and Evaluation of SHARE: A Palliative Care Intervention for Head and Neck Cancer Patients and their Caregivers
SHARE 的适应和评估:针对头颈癌患者及其护理人员的姑息治疗干预措施
  • 批准号:
    10216592
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Improving Self-management in Head and Neck Cancer
改善头颈癌的自我管理
  • 批准号:
    9337152
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
Improving Self-management in Head and Neck Cancer
改善头颈癌的自我管理
  • 批准号:
    8752355
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    8748544
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    9326815
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    8906834
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了